3 top FTSE 350 stocks I’d buy today

Can you afford to miss these three FTSE 350 (INDEXFTSE:NMX) shares from this bargain sector?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Inflation is on the rise as we head for Brexit and out of the EU single market, and the falling pound is already pushing up prices of imports. In this environment, from an investment viewpoint I’d be steering clear of anything that depends on discretionary retail spending. But with isolation increasing in these Trump-darkened times, I can see a good time ahead for investing in the defence business.

On the up

Look at QinetiQ (LSE: QQ), whose shares are up 15% over the past 12 months, to 272p. It delivered a third-quarter update on 15 February, which spoke of “encouraging progress in the implementation of its strategy to drive future growth“.

Key strategic progress includes a £1bn amendment to the firm’s long-term partnering agreement (LTPA) with the Ministry of Defence, and QinetiQ’s acquisition of Meggit’s Target System division, both in December. Financially, trading is going as expected, with the LTPA amendment adding around £10m to capital expenditure this year. A £50m share buyback programme is nearing completion.

The gain in the share price has lifted QinetiQ’s forward P/E multiples to around 17 for the next couple of years, which is a bit ahead of the FTSE average. That makes me a little cautious, but it’s probably a fair valuation for a safe investment in these troubled times.

Big loss

Rolls-Royce (LSE: RR) reported a pre-tax loss of £4.6bn this week. That included writedowns for various reasons, but it’s still the company’s biggest ever loss and is up there with some of the most eye-watering that UK companies have ever produced.

At 695p, the shares are down 6% since the results emerged, but I reckon we should be focusing on the company’s transformation plan. After a couple of very tough years, which brought a string of profit warnings to shock the industry, analysts are now predicting a return to earnings growth.

There’s a 16% EPS rise on the cards for 2017, followed by a further 4% the year after. And the dividend, which was slashed in 2015 and cut further for 2016, should start climbing back again.

We are looking at a predicted P/E of 19 and a modest 2% dividend yield for 2018, but if we genuinely are at a pivot point in Rolls-Royce’s recovery, I think that could turn out to be a good valuation to buy at. And with Warren East, the former head of ARM Holdings, at the helm, I’m once again cautiously optimistic.

The best?

My final pick is my favourite in the sector, BAE Systems (LSE: BA). While rivals have been in the headlines (largely for the wrong reasons), BAE has been bringing in steady earnings and paying out solid dividends. Due to the nature of payments for its long-term contracts, earnings can be a little erratic in the short term, and forecasts put EPS at 45.6p by 2018. That’s exactly the same as in 2011, but considering the trading difficulties faced by the sector in recent years years, I think that’s a decent track record.

Dividends have been creeping up, although the share price performance over the fast five years (a 90% rise to 602p) has dropped prospective yields to around the 3.6% level.

BAE’s 2016 results should be with us on 23 February, as the firm expects underlying earnings per share to come in around 5%-10% above last year’s figure. On a forward P/E of 14, BAE looks like top value to me.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »